These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1329014)

  • 1. [LH-RH agonist in subjects treated with growth hormone for somatotropin deficiency. Development of growth velocity and prediction of body height].
    Leheup B; Schaeffer L; Jeandel C; Pierson M
    Pediatrie; 1992; 47(4):291-5. PubMed ID: 1329014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined use of growth hormone and gonadotropin-releasing hormone analogues: the national cooperative growth study experience.
    Kohn B; Julius JR; Blethen SL
    Pediatrics; 1999 Oct; 104(4 Pt 2):1014-8. PubMed ID: 10506254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of puberty in growth hormone deficient children.
    Saggese G; Federico G; Barsanti S
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():329-34. PubMed ID: 10698597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of combined treatment with growth hormone and gonadotropin releasing hormone analogue in children with poor prognosis of adult height.
    Toumba M; Bacopoulou I; Savva SC; Skordis N
    Indian Pediatr; 2007 Jul; 44(7):497-502. PubMed ID: 17684302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
    Lanes R; Gunczler P
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined treatment with growth hormone and gonadotropin-releasing hormone analogues in children with isolated growth hormone deficiency.
    Saggese G; Cesaretti G; Andreani G; Carlotti C
    Acta Endocrinol (Copenh); 1992 Oct; 127(4):307-12. PubMed ID: 1449042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acceleration of pubertal development].
    Antoniazzi F; Zamboni G; Tatò L
    Pediatr Med Chir; 1996; 18(1):19-25. PubMed ID: 8685017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of treatment combining an agonist of gonadotropin-releasing hormone with growth hormone in pubertal patients with isolated growth hormone deficiency.
    Toublanc JE; Couprie C; Garnier P; Job JC
    Acta Endocrinol (Copenh); 1989 Jun; 120(6):795-9. PubMed ID: 2524948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of GnRH agonists in GH-deficient patients: arguments for and against. The case for GnRH agonists in GH-deficient patients.
    Lee PA
    Pediatr Endocrinol Rev; 2008 Feb; 5 Suppl 2():744-9. PubMed ID: 18317446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Final height after treatment of early puberty in short adopted girls with gonadotrophin releasing hormone agonist with or without growth hormone.
    Mul D; Oostdijk W; Waelkens JJ; Drop SL
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):185-90. PubMed ID: 16060912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone and GnRHa combination therapy in the management of precocious puberty.
    Khadilkar VV; Khadilkar VV; Maskati GB
    Indian Pediatr; 2005 Jan; 42(1):57-60. PubMed ID: 15695861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone.
    Cara JF; Kreiter ML; Rosenfield RL
    J Pediatr; 1992 May; 120(5):709-15. PubMed ID: 1533661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-term growth hormone therapy on bone age and pubertal maturation in boys with and without classic growth hormone deficiency.
    Zadik Z; Chalew S; Zung A; Landau H; Leiberman E; Koren R; Voet H; Hochberg Z; Kowarski AA
    J Pediatr; 1994 Aug; 125(2):189-95. PubMed ID: 8040760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapy with luteinizing hormone releasing hormone agonist (LHRHa) and growth hormone (GH) in central precocious puberty.
    Volta C; Regazzi C; Ndaka J; Vitale R; Bernasconi S
    Acta Biomed; 2005 Sep; 76(2):73-8. PubMed ID: 16350551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of administering gonadotropin-releasing hormone agonist with recombinant-human growth hormone (GH) on the final height of girls with isolated GH deficiency: results from a controlled study.
    Saggese G; Federico G; Barsanti S; Fiore L
    J Clin Endocrinol Metab; 2001 May; 86(5):1900-4. PubMed ID: 11344181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expensive therapies in children: benefit versus cost of combined treatment of recombinant human growth hormone and gonadotropin-releasing hormone analogue in girls with poor height potential.
    Toumba M; Kokotsis V; Savva SC; Skordis N
    J Pediatr Endocrinol Metab; 2014 Mar; 27(3-4):311-6. PubMed ID: 24158419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure to improve height prediction in short-stature pubertal adolescents by inhibiting puberty with luteinizing hormone-releasing hormone analogue.
    Lindner D; Job JC; Chaussain JL
    Eur J Pediatr; 1993 May; 152(5):393-6. PubMed ID: 8319702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of luteinizing hormone-releasing hormone analog-induced pubertal delay in growth hormone (GH)-deficient children treated with GH: preliminary results.
    Cassorla F; Mericq V; Eggers M; Avila A; García C; Fuentes A; Rose SR; Cutler GB
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3989-92. PubMed ID: 9398701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final height of patients with idiopathic growth hormone deficiency after long-term growth hormone treatment. Committee for Treatment of Growth Hormone Deficient Children, Growth Science Foundation, Japan.
    Hibi I; Tanaka T
    Acta Endocrinol (Copenh); 1989 Apr; 120(4):409-15. PubMed ID: 2718695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a place for combined therapy with GnRH agonist plus growth hormone in improving final height in short statured children?
    Saggese G; Federico G; Barsanti S; Cerri S
    J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():821-6. PubMed ID: 10969927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.